Our top pick for
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Marrone Bio Innovations, Inc is an agricultural inputs business based in the US. Marrone Bio Innovations shares (MBII) are listed on the NASDAQ and all prices are listed in US Dollars. Marrone Bio Innovations employs 145 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$1.40|
|52-week range||$1.06 - $2.90|
|50-day moving average||$1.60|
|200-day moving average||$1.84|
|Wall St. target price||$3.23|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.19|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-07-24)||N/A|
|1 month (2021-07-02)||-15.66%|
|3 months (2021-05-04)||-20.45%|
|6 months (2021-01-31)||N/A|
|1 year (2020-07-31)||N/A|
|2 years (2019-07-31)||N/A|
|3 years (2018-07-31)||N/A|
|5 years (2016-07-31)||N/A|
|Revenue TTM||$39.8 million|
|Gross profit TTM||$22.9 million|
|Return on assets TTM||-10.98%|
|Return on equity TTM||-54.49%|
|Market capitalisation||$236.7 million|
TTM: trailing 12 months
There are currently 1.5 million Marrone Bio Innovations shares held short by investors – that's known as Marrone Bio Innovations's "short interest". This figure is 0.4% up from 1.5 million last month.
There are a few different ways that this level of interest in shorting Marrone Bio Innovations shares can be evaluated.
Marrone Bio Innovations's "short interest ratio" (SIR) is the quantity of Marrone Bio Innovations shares currently shorted divided by the average quantity of Marrone Bio Innovations shares traded daily (recently around 423315.21126761). Marrone Bio Innovations's SIR currently stands at 3.55. In other words for every 100,000 Marrone Bio Innovations shares traded daily on the market, roughly 3550 shares are currently held short.
However Marrone Bio Innovations's short interest can also be evaluated against the total number of Marrone Bio Innovations shares, or, against the total number of tradable Marrone Bio Innovations shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Marrone Bio Innovations's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Marrone Bio Innovations shares in existence, roughly 10 shares are currently held short) or 0.0182% of the tradable shares (for every 100,000 tradable Marrone Bio Innovations shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Marrone Bio Innovations.
Find out more about how you can short Marrone Bio Innovations stock.
We're not expecting Marrone Bio Innovations to pay a dividend over the next 12 months.
Over the last 12 months, Marrone Bio Innovations's shares have ranged in value from as little as $1.06 up to $2.9. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Marrone Bio Innovations's is 0.1828. This would suggest that Marrone Bio Innovations's shares are less volatile than average (for this exchange).
Marrone Bio Innovations, Inc. discovers, develops, produces, and promotes biological products for pest management, plant nutrition, and plant health in the United States and internationally. Its products include Emergen, Foramin, Foramin ST, Pacesetter, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bioinsecticide that controls sucking and chewing insects through feeding; Haven, a plant health product to reduce sun stress and dehydration; Jet-Ag and Jet-Oxide peroxyacetic acid sanitizers that prevent, suppress, eliminate, and control algae, fungi, and bacterial diseases in agriculture and horticultural industries; and Majestene, a bionematicide to control soil-dwelling nematodes and certain soil borne insects. The company also offers Regalia and Stargus, which are bio fungicides that protects against fungal and bacterial diseases and enhances yields/quality; Venerate, a bioinsecticide, which controls chewing and sucking insects and mites, as well as flies and plant parasitic nematodes; and Zelto, a bionematicide that protects turf, including golf course fairways and greens, and promotes turf health by enhancing plant and root health. The company provides its products directly through sales force, as well as through distributors and other commercial partners. The company formerly known as Marrone Organic Innovations, Inc. Marrone Bio Innovations, Inc.
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
Everything we know about the RenovoRx IPO, plus information on how to buy in.
Everything we know about the Draganfly IPO, plus information on how to buy in.
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
Everything we know about the Marpai IPO, plus information on how to buy in.
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.